BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 25594553)

  • 1. Immune reconstitution/immunocompetence in recipients of kidney plus hematopoietic stem/facilitating cell transplants.
    Leventhal JR; Elliott MJ; Yolcu ES; Bozulic LD; Tollerud DJ; Mathew JM; Konieczna I; Ison MG; Galvin J; Mehta J; Badder MD; Abecassis MM; Miller J; Gallon L; Ildstad ST
    Transplantation; 2015 Feb; 99(2):288-98. PubMed ID: 25594553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term Nonhuman Primate Renal Allograft Survival Without Ongoing Immunosuppression in Recipients of Delayed Donor Bone Marrow Transplantation.
    Hotta K; Oura T; Dehnadi A; Boskovic S; Matsunami M; Rosales I; Smith RN; Colvin RB; Cosimi AB; Kawai T
    Transplantation; 2018 Apr; 102(4):e128-e136. PubMed ID: 29300231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducing Transient Mixed Chimerism for Allograft Survival Without Maintenance Immunosuppression With Combined Kidney and Bone Marrow Transplantation: Protocol Optimization.
    Lee KW; Park JB; Park H; Kwon Y; Lee JS; Kim KS; Chung YJ; Rhu JS; Choi S; Kwon GY; Kim HJ; Kang ES; Jung CW; Shin EC; Kawai T; Kim SJ; Joh JW
    Transplantation; 2020 Jul; 104(7):1472-1482. PubMed ID: 31634324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Living-Donor Kidney Transplant With Preformed Donor-Specific Antibodies.
    Itabashi Y; Aikawa A; Muramatsu M; Hyoudou Y; Shinoda K; Takahashi Y; Sakurabayashi K; Mizutani T; Oguchi H; Arai T; Kawamura T; Hamasaki Y; Sakai K; Shishido S
    Exp Clin Transplant; 2019 Jan; 17(Suppl 1):43-49. PubMed ID: 30777522
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful Induction of Specific Immunological Tolerance by Combined Kidney and Hematopoietic Stem Cell Transplantation in HLA-Identical Siblings.
    Fehr T; Hübel K; de Rougemont O; Abela I; Gaspert A; Güngör T; Hauri M; Helmchen B; Linsenmeier C; Müller T; Nilsson J; Riesterer O; Scandling JD; Schanz U; Cippà PE
    Front Immunol; 2022; 13():796456. PubMed ID: 35173720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allogeneic hematopoietic stem-cell transplantation, mixed chimerism, and tolerance in living related donor renal allograft recipients.
    Trivedi HL; Vanikar AV; Modi PR; Shah VR; Vakil JM; Trivedi VB; Khemchandani SI
    Transplant Proc; 2005 Mar; 37(2):737-42. PubMed ID: 15848518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA identical non-chimeric and HLA disparate chimeric renal transplant tolerance.
    Leventhal JR; Mathew JM; Ildstad S; Salomon DR; Kurian SM; Suthanthiran M; Tambur A; Friedewald J; Gallon L; Charette J; Levitsky J; Kanwar Y; Abecassis M; Miller J
    Clin Transpl; 2013; ():145-56. PubMed ID: 25095503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Ex Vivo-Expanded Recipient Regulatory T Cells on Hematopoietic Chimerism and Kidney Allograft Tolerance Across MHC Barriers in Cynomolgus Macaques.
    Duran-Struuck R; Sondermeijer HP; Bühler L; Alonso-Guallart P; Zitsman J; Kato Y; Wu A; McMurchy AN; Woodland D; Griesemer A; Martinez M; Boskovic S; Kawai T; Cosimi AB; Yang YG; Hu Z; Wuu CS; Slate A; Mapara M; Baker S; Tokarz R; D'Agati V; Hammer S; Pereira M; Lipkin WI; Wekerle T; Levings M; Sykes M
    Transplantation; 2017 Feb; 101(2):274-283. PubMed ID: 27846155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tolerance induction in HLA disparate living donor kidney transplantation by donor stem cell infusion: durable chimerism predicts outcome.
    Leventhal J; Abecassis M; Miller J; Gallon L; Tollerud D; Elliott MJ; Bozulic LD; Houston C; Sustento-Reodica N; Ildstad ST
    Transplantation; 2013 Jan; 95(1):169-76. PubMed ID: 23222893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerance induction in HLA disparate living donor kidney transplantation by facilitating cell-enriched donor stem cell Infusion: The importance of durable chimerism.
    Leventhal JR; Ildstad ST
    Hum Immunol; 2018 May; 79(5):272-276. PubMed ID: 29409743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression.
    Kawai T; Sachs DH; Sprangers B; Spitzer TR; Saidman SL; Zorn E; Tolkoff-Rubin N; Preffer F; Crisalli K; Gao B; Wong W; Morris H; LoCascio SA; Sayre P; Shonts B; Williams WW; Smith RN; Colvin RB; Sykes M; Cosimi AB
    Am J Transplant; 2014 Jul; 14(7):1599-611. PubMed ID: 24903438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical strategy for induction of transplantation tolerance through mixed chimerism.
    Cosimi AB; Sachs DH; Sykes M; Kawai T
    Clin Transpl; 2013; ():127-34. PubMed ID: 25095501
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinically feasible approach to induce delayed tolerance in recipients of prior kidney or vascularized composite allotransplants.
    Chen B; Xu H; Corbin DR; Ildstad ST
    Transplantation; 2012 Oct; 94(7):671-8. PubMed ID: 22948444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimerism and tolerance without GVHD or engraftment syndrome in HLA-mismatched combined kidney and hematopoietic stem cell transplantation.
    Leventhal J; Abecassis M; Miller J; Gallon L; Ravindra K; Tollerud DJ; King B; Elliott MJ; Herzig G; Herzig R; Ildstad ST
    Sci Transl Med; 2012 Mar; 4(124):124ra28. PubMed ID: 22399264
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Immunocompetence and Biomarkers of Tolerance in Chimeric and Immunosuppression-free Kidney Allograft Recipients.
    Leventhal JR; Galvin J; Ison MG; Feng CY; Ding R; Lee JR; Li C; Mathew JM; Gallon L; Gibson M; Belshe D; Tollerud DJ; Gornstein E; Suthanthiran M; Ildstad ST
    Transplantation; 2023 Oct; 107(10):e257-e268. PubMed ID: 37370204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.
    Donckier V; Troisi R; Toungouz M; Colle I; Van Vlierberghe H; Jacquy C; Martiat P; Stordeur P; Zhou L; Boon N; Lambermont M; Schandené L; Van Laethem JL; Noens L; Gelin M; de Hemptinne B; Goldman M
    Transpl Immunol; 2004; 13(2):139-46. PubMed ID: 15380544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of Major Histocompatibility Complex-mismatched Mouse Lung Allograft Acceptance With Combined Donor Bone Marrow: Lung Transplant Using a 12-Hour Nonmyeloablative Conditioning Regimen.
    Dodd-O JM; Ganguly S; Vulic A; Panoskaltsis-Mortari A; McDyer JF; Luznik L
    Transplantation; 2016 Dec; 100(12):e140-e146. PubMed ID: 27861294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term immune reconstitution and infection burden after mismatched hematopoietic stem cell transplantation.
    Servais S; Lengline E; Porcher R; Carmagnat M; Peffault de Latour R; Robin M; Sicre de Fontebrune F; Clave E; Maki G; Granier C; Xhaard A; Dhedin N; Molina JM; Toubert A; Moins-Teisserenc H; Socie G
    Biol Blood Marrow Transplant; 2014 Apr; 20(4):507-17. PubMed ID: 24406505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addition of Anti-CD40 Monoclonal Antibody to Nonmyeloablative Conditioning With Belatacept Abrogated Allograft Tolerance Despite Induction of Mixed Chimerism.
    Oura T; Hotta K; Rosales I; Dehnadi A; Kawai K; Lee H; Benedict Cosimi A; Kawai T
    Transplantation; 2019 Jan; 103(1):168-176. PubMed ID: 30113996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Luminex Solid-Phase Crossmatch for De Novo Donor-Specific Antibodies in Living-Donor Related Transplants.
    Mehrotra S; Sharma RK; Mayya M; Gupta A; Prasad N; Kaul A; Bhadauria DS
    Exp Clin Transplant; 2017 Aug; 15(4):394-399. PubMed ID: 28447925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.